-
A committee of scientists led by Johns Hopkins investigators has published a new guide to the biology, diagnosis and treatment of lung cancer in never-smokers, fortifying measures for what physicians have long known is a very different disease than in smokers.
Johns Hopkins Hospital (Pneumologia) - Ven, 18 Settembre 2009
http://www.hopkinshospital.org
-
We know, from observational trials, that body weight loss is useful in the treatment of obstructive sleep apnea syndrome (OSAS); now, some Finnish researchers have performed a randomized trial to verify the usefulness of weight loss in mild OSAS. 81 overweight and obese adults (BMI between 28 and 40), affected by mild forms of OSAS (5-15 events of apneas/hypopneas per hour) and with a counselling lasted 12 weeks concerning lifestyle have been enrolled.
MedNews (Pneumologia) - Lun, 14 Settembre 2009
http://mn.medsurfnews.com/
-
The advent of antibiotics led to dramatic reductions in mortality and medical complications from bacterial respiratory tract infections. Although the armamentarium of diagnostic and therapeutic approaches has increased exponentially since that time, the effect of these advances on patient outcomes is less dramatic
Journal of the American Medical Association (Pneumologia) - Lun, 14 Settembre 2009
http://jama.ama-assn.org/
-
Great advances in medicine were achieved following application of statistical analysis to research findings in the early 20th century. Armed with a formal mechanism to analyze data, investigators could reject empirical claims that treatments such as blistering and bloodletting were beneficial. Structured clinical trials with results analyzed in objective ways paved the way for improved health care by proving that vaccinations and surgical antisepsis were effective.
Archives of Surgery (Pneumologia) - Lun, 14 Settembre 2009
http://archsurg.ama-assn.org/
-
On Sept 12–16, Vienna hosts the European Respiratory Society's annual congress, the largest in pulmonary medicine in the world. As a prelude to the meeting, The Lancet today is devoted to chronic obstructive pulmonary disease (COPD). WHO estimates that 210 million people have COPD worldwide. This number could be higher because many people with COPD often do not seek medical help until the disease worsens. COPD is now an umbrella term to cover emphysema and chronic bronchitis, among others, all of which used to be considered separate conditions. The disease is the fourth leading cause of death in the world, but by 2030 it is expected to be the third, behind ischaemic heart disease and cerebrovascular disease.
The Lancet (Pneumologia) - Ven, 28 Agosto 2009
http://www.thelancet.com
-
A new low-energy heat treatment for asthma patients may provide some relief, according to experts at Baylor College of Medicine . Multinational study Baylor's NIH funded Asthma Center was selected to take part in a multinational study to see if bronchial thermoplasty is effective in treating asthma.
Baylor College of Medicine (Pneumologia) - Lun, 13 Luglio 2009
http://www.bcm.edu
-
Asthma affects about 24 million Americans and has a higher prevalence in the inner city population, said Hanania. Treatment for asthma depends on its severity and incorporates anti-inflammatory medications and lifestyle changes.
Baylor College of Medicine (Pneumologia) - Lun, 13 Luglio 2009
http://www.bcm.edu
-
It is well known that macrolides have an anti-inflammatory activity separated from their anti-bacterial activity, so some English researchers, starting from the presupposition that both these properties are useful in COPD, have performed a randomized trial on the prophylaxis of the relapses of this chronic disease.
MedNews (Pneumologia) - Ven, 3 Luglio 2009
http://mn.medsurfnews.com/
-
Two popular anti-smoking drugs will now carry warnings about the risk of severe mental health problems, the Food and Drug Administration announced Wednesday.
CNN.com (Pneumologia) - Ven, 3 Luglio 2009
http://www.cnn.com
-
This review discusses important advances in fungal diagnostics and in the antifungal armamentarium as applied to aspergillus species. Recent insights concerning host defenses against aspergillus species and the immunopathogenesis of aspergillus-related diseases are presented.
New England Journal of Medicine (Pneumologia) - Gio, 30 Aprile 2009
http://www.nejm.org